ArticleJHEP reports : innovation in hepatology2022

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates.

Sabela Lens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.